HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis.

NCT07712705 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

515

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: HPP737
DRUG: Placebo matching HPP737

Sponsor

Newsoara Biopharma Co., Ltd.